age related macular degeneration Market Outlook 2025-2034: Trends and Projections

What is the Projected Age-Related Macular Degeneration Market Size and Growth Rate?
The market size for age-related macular degeneration has seen robust growth in past years, expanding from $9.96 billion in 2024 to expected $10.7 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.5%. This significant growth in the historic period can be attributed to factors like an aging population, changing lifestyles, and environmental factors, genetic predisposition, increased awareness, early diagnosis, and advancements in diagnostic techniques.

The market size is projected to see substantial growth in the next few years, expanding further to $14.38 billion in 2029 at a CAGR of 7.7%. This growth in the forecast period can be attributed to advancements in genetics and biomarkers research, emergence of new therapeutic modalities, utilization of telemedicine and increased patient advocacy and education. Trends likely to manifest during the forecast period include personalized medicine approaches, innovations in retinal imaging technologies, emergence of sustained drug delivery systems, collaborations for research and development.

Get Your Free Sample of The Global Age-Related Macular Degeneration Global Market Report 2025 Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10845&type=smp

What Factors are Driving the Age-Related Macular Degeneration Market Growth?
The escalating prevalence of age-related macular degeneration (AMD) is driving the market growth. This condition affects the macula, a small part of the retina responsible for central vision, progressing over time. The treatments for AMD aid patients suffering from retinal disorders by lessening the severity of the disease condition. According to Optimaxa, a UK-based laser eye treatment specialist, it is estimated that AMD affected 196 million individuals globally in February 2023 and is projected to reach 288 million by 2040, accounting for 8.7% of the world’s population.

Which Are the Major Segments in the Age-Related Macular Degeneration Market?
1) By Type: Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)
2) By Drug: Eylea, Lucentis, Avastin, Other Products
3) By Route Of Administration: Intravenous, Intravitreal
4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy

Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report

Who are the Major Players in the Age-Related Macular Degeneration Market?
Prominent companies operating in the age-related macular degeneration market include F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., AbbVie Inc., Outlook Therapeutics Inc., Biogen Inc., Samsung Bioepis Co. Ltd., and others.

What are the Emerging Trends in the Age-Related Macular Degeneration Market?
Key players in the age-related macular degeneration (AMD) market are developing innovative treatments, like bispecific antibodies, which can result in reduced treatment frequency. For example, Chugai Pharmaceutical Co., Ltd. recently launched Vabysmo, a groundbreaking therapy that targets angiopoietin-2 and Vascular Endothelial Growth Factor-A, contributing factors to abnormal blood vessel growth and inflammation.

Which Region Will Experience the Fastest Growth in the Age-Related Macular Degeneration Market?
While North America was the largest region in the global age-related macular degeneration market in 2024, Asia-Pacific is predicted to be the fastest-growing region in the future. Other regions covered in the report include Western Europe, Eastern Europe, South America, Middle East, and Africa.

What Does The Age-Related Macular Degeneration Global Market Report 2025 Offer?
Age-related macular degeneration refers to a progressive condition where the macula, located at the center of the retina, deteriorates. It occurs due to aging and leads to a decline in central vision. Treatment options include regular eye exams, lifestyle changes, and specific nutritional supplements. The Age-Related Macular Degeneration Global Market Report 2025 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10845.

About The Business Research Company
The Business Research Company renowned for delivering comprehensive and data-rich research insights. With over 15000+ reports from 27 industries covering 60+ geographies, we provide the information you need to stay ahead. Our global market model, a premier market intelligence platform, delivers comprehensive forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *